How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment [Yahoo! Finance]
PAVmed Inc. (PAVM)
US:NASDAQ Investor Relations:
ir.pavm.com
Company Research
Source: Yahoo! Finance
PAVmed's latest analyst update centers on a recalibrated price target, with fair value moving from US$510.00 to US$263.00, a reduction of roughly 48% that materially reshapes the headline valuation. Analysts describe this shift as a reset of key inputs to align the target with their latest research rather than a simple call on where the business should trade next. As you read on, you will see how to interpret this evolving narrative and what to watch for as the story develops. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value PAVmed. What Wall Street Has Been Saying ?? Bullish Takeaways Even with a lower price target, Maxim continues to publish research on PAVmed, which signals that the firm still sees the name as worth following and modeling rather than stepping away entirely. The latest report from Maxim frames the new target as a reset of key inputs, which can indicate that the firm is refining its assump
Show less
Read more
Impact Snapshot
Event Time:
PAVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PAVM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PAVM alerts
High impacting PAVmed Inc. news events
Weekly update
A roundup of the hottest topics
PAVM
News
- PAVmed (PAVM) had its price target lowered by Ascendiant Capital Markets from $510.00 to $65.00. They now have a "buy" rating on the stock.MarketBeat
- Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- PAVmed (PAVM) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=PAVM&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" to "hold".MarketBeat
- PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio [Yahoo! Finance]Yahoo! Finance
- PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio [TheStreet.com]TheStreet.com
PAVM
Earnings
- 11/13/25 - Beat
PAVM
Sec Filings
- 4/14/26 - Form SCHEDULE
- 4/13/26 - Form 4
- 4/13/26 - Form 3
- PAVM's page on the SEC website